In Parkinsons disease, gut dysbacteriosis and gastrointestinal dysfunctions can precede the neurological symptoms, suggesting a pathophysiological role of the intestine
1 Strong Weight Loss Supports Monthly GLP-1 Strategy The Phase 2b VESPER program evaluated weekly and monthly dosing in patients with obesity or overweight, with and without type 2 diabetes
and/or Imported or manufactured in Australia as therapeutic goods, or for use in therapeutic goods, for supply, in accordance with the Therapeutic Goods Act 1989
14a and b)
Br J Pharmacol 177(8):18061821 Li ZY, Wu G, Qiu C, Zhou ZJ, Wang YP, Song GH, Xiao C, Zhang X, Deng GL, Wang RT, Yang YL (2022) Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments